Neurocrine Biosciences, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64125C1099
USD
165.24
2.12 (1.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryNeurocrine Biosciences, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.3%
-0.26%
1W
6.72%
-2.93%
1M
8.53%
-0.17%
YTD
16.51%
7.91%
1Y
31.42%
22.99%
3Y
76.94%
71.83%
5Y
67.89%
75.06%
10Y
231.34%
249.17%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
27.18%
0%
27.18%
6 Months
6.59%
0%
6.59%
1 Year
31.42%
0%
31.42%
2 Years
22.43%
0%
22.43%
3 Years
76.94%
0%
76.94%
4 Years
69.83%
0%
69.83%
5 Years
67.89%
0%
67.89%

Neurocrine Biosciences, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary